Word: lymphomas
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Like the women's-rights movement she has helped lead since the 1970S, Gloria Steinem has come a long way. Proudly single until four years ago, when she married environmentalist David Bale, she became a widow in December when he died of brain lymphoma. TIME's Sonja Steptoe talked with Steinem, who turned 70 last week, and found her just as engaged as ever...
...sadness and anger--forces that he's not quite able to acknowledge directly; it's as if they're happening in the corner of his eye, just beyond the spectrum of the visible. His son Jack is barely keeping the company together. His daughter Theresa is fighting non-Hodgkins lymphoma. His dad is in a nursing home and miserable there. His last girlfriend, the foxy Rita, left him a year ago, and he's not quite as over it as he'd like to think. Nor, come to think of it, has he ever really dealt with the madness...
...discovery firm. "There's a lot of concern about losing your money." Mullen's focus on diverse products, production synergies and profitability is already part of the culture at top industry players Amgen and Genentech. Biogen's Avonex for multiple sclerosis and IDEC's Rituxan for non-Hodgkin's lymphoma each generate more than $1 billion in annual sales, and both companies are solidly profitable. Yet "the combination will create more value than either could as separate entities," says William Rastetter, ceo of IDEC. That's why a wave of mergers could sweep the industry. There are only about three...
...also doesn't take a rocket scientist to figure out this is junk science. School officials dispute the numbers Brockovich is throwing about. They say 216 claims have been filed against the school district, and only 94 of them involve cancers. And what about those specific cancers - Hodgkin's Lymphoma, non-Hodgkin's Lymphoma and thyroid cancer - listed in the initial suit filed against the oil companies by the Brockovich firm? As the University of Southern California medical school's Cancer Surveillance Program flatly states, "Known causes of these cancers are not petroleum or petroleum products...
...proposed Biogen IDEC, where he would be CEO, is already part of the culture at top industry players Amgen and Genentech. So he's got a blueprint--and a lot to work with. Biogen's Avonex for multiple sclerosis and IDEC's Rituxan for non-Hodgkin's lymphoma each generate more than $1 billion in annual sales, and both companies are solidly profitable. Yet "the combination will create more value than either could as separate entities," says William Rastetter, CEO of IDEC, who would get the title of executive chairman after the merger. The focus on managing will probably spill...